Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-17-009915
Filing Date
2017-09-22
Accepted
2017-09-22 15:07:48
Documents
1
Period of Report
2017-07-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3071117wolfe_dandrit.html 3  
1 OWNERSHIP DOCUMENT f3071117wolfe_dandrit.xml 3 1672
  Complete submission text file 0001213900-17-009915.txt   3075
Mailing Address STUMPEDYSSEVEJ 17, 2970 H?RSHOLM G7
Business Address STUMPEDYSSEVEJ 17, 2970 H?RSHOLM G7 45 39179840
DanDrit Biotech USA, Inc. (Issuer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address PO BOX 189 RANDOLPH VT 05060
Business Address
Wolfe Robert (Reporting) CIK: 0001600148 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54478 | Film No.: 171097485